{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:23:33Z","timestamp":1787167413041,"version":"build-2736575974"},"reference-count":13,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":233,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Med Austriaca"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>\n                    <jats:bold>Zusammenfassung:<\/jats:bold>\n                    Tumormarker sind Substanzen, welche in Tumorzellen produziert bzw. deren Synthesen durch maligne Zellen induziert werden und im Blut oder in anderen K\u00f6rperfl\u00fcssigkeiten durch nichtinvasive Methoden nachgewiesen werden k\u00f6nnen. Die Ursache f\u00fcr die gesteigerte Tumormarkersynthese ist in der Transformation von physiologischen zu malignen Zellen zu sehen. Da jedoch auch andere proliferative Prozesse, wie entz\u00fcndliche Ver\u00e4nderungen oder benigne Tumoren zu einer Tumormarkersynthese f\u00fchren k\u00f6nnen, ist der Aussagewert erh\u00f6hter Markerkonzentrationen erheblich eingeschr\u00e4nkt. Bis heute sind Tumormarker, mit Ausnahme des PSA, nicht zum Screening geeignet, auch k\u00f6nnen diese nur in wenigen F\u00e4llen zur Tumorlokalisation (Calcitonin, TG und \u03b2\u2010HCG) herangezogen werden. Wenngleich die H\u00f6he der Markerkonzentrationen bei metastasierten Tumoren zumeist deutlich h\u00f6her liegt als bei organbegrenzten Malignomen, ist ein R\u00fcckschluss auf Tumorgr\u00f6\u00dfe\/Stadium nicht zul\u00e4ssig. Hilfreich sind Tumormarker hingegen in der Verlaufskontrolle zur Rezidivfr\u00fcherkennung und zum Monitoring palliativer Therapiekonzepte.\n                  <\/jats:p>","DOI":"10.1046\/j.1563-2571.2001.01008.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T20:52:16Z","timestamp":1047329536000},"page":"33-37","source":"Crossref","is-referenced-by-count":5,"title":["Tumormarker"],"prefix":"10.1111","volume":"28","author":[{"given":"W.","family":"Fiebiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch.","family":"Wiltschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_17_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2843"},{"key":"e_1_2_17_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000216551"},{"key":"e_1_2_17_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.1999.0151"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1066839"},{"key":"e_1_2_17_6_2","first-page":"3613","article-title":"Tumour markers CEA, NSE, SCC, TPA and CYFRA\u200321\u20101 in resectable non\u2010small cell lung cancer","volume":"19","author":"Foa P","year":"1999","journal-title":"Anticancer Research"},{"key":"e_1_2_17_7_2","volume-title":"Internistische Onkologie","author":"Lamerz R","year":"2000"},{"key":"e_1_2_17_8_2","first-page":"4485","article-title":"Long\u2010term follow up study in breast cancer patients using serum tumor markers CEA and CA\u200315\u20103","volume":"19","author":"Lumachi F","year":"1999","journal-title":"Anticancer Research"},{"key":"e_1_2_17_9_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1174"},{"key":"e_1_2_17_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004280050450"},{"key":"e_1_2_17_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67807-X"},{"key":"e_1_2_17_12_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"NIH consensus conference. Ovarian cancer, screening, treatment, and follow\u2010up","volume":"273","author":"NIH\u2010Consensus\u2010Development\u2010Panel","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_17_13_2","first-page":"901","volume-title":"Labor und Diagnose","author":"Thomas L","year":"1992"},{"key":"e_1_2_17_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(20000101)88:1<162::aid-cncr22>3.0.co;2-v"}],"container-title":["Acta Medica Austriaca"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1563-2571.2001.01008.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1563-2571.2001.01008.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:40:48Z","timestamp":1697478048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1563-2571.2001.01008.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1046\/j.1563-2571.2001.01008.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1563-2571.2001.01008.x","archive":["Portico"],"relation":{},"ISSN":["0303-8173","1563-2571"],"issn-type":[{"value":"0303-8173","type":"print"},{"value":"1563-2571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}